Copyright
©The Author(s) 2015.
World J Gastroenterol. Nov 14, 2015; 21(42): 12125-12140
Published online Nov 14, 2015. doi: 10.3748/wjg.v21.i42.12125
Published online Nov 14, 2015. doi: 10.3748/wjg.v21.i42.12125
Organ failure | 0 | 1 | 2 | 3 | 4 |
Liver (Tbil, mg/L) | < 1.2 | ≥ 1.2 to < 2.0 | ≥ 2.0 to < 6.0 | ≥ 6.0 to < 12 | ≥ 12.0 |
Kidney (cr, mg/dL) | < 1.2 | ≥ 1.2 to < 2.0 | ≥ 2.0 to < 3.5 | ≥ 6.0 to < 12 | ≥ 5.0 |
Or use of renal replacement therapy | |||||
Cerebral (HE grade) | No HE | I | II | III | IV |
Coagulation (INR) | < 1.1 | ≥ 1.1 to < 1.25 | ≥ 1.25 to < 1.5 | ≥ 1.5 to < 2.5 | ≥ 2.5 or PLT ≤ 20 × 109/L |
Circulation (MAP, mmHg) | ≥ 70 | < 70 | DA ≤ 5 or DOB or Terlipressin | DA > 5 or E ≤ 0.1 or NE ≤ 0.1 | DA > 15 or E 0.1 or NE > 0.1 |
Lung PaO2/FiO2 | > 400 | > 300 to ≤ 400 | > 200 to ≤ 300 | > 100 to ≤ 200 | ≤ 100 |
Or SpO2/FiO2 | > 512 | > 357 to ≤ 512 | > 214 to ≤ 357 | > 89 to ≤ 214 | ≤ 89 |
- Citation: Blasco-Algora S, Masegosa-Ataz J, Gutiérrez-García ML, Alonso-López S, Fernández-Rodríguez CM. Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management. World J Gastroenterol 2015; 21(42): 12125-12140
- URL: https://www.wjgnet.com/1007-9327/full/v21/i42/12125.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i42.12125